Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 23, 2001 - Issue 2-3: Neurotrauma
35
Views
19
CrossRef citations to date
0
Altmetric
Articles

Design and statistical issues in multicenter trials of severe head injury

&
Pages 190-192 | Published online: 19 Jul 2013

REFERENCES

  • Choi SC, Marmarou A, Bullock R, et al. Primary endpoints in Phase III trials of severe head trauma: DRS versus GOS. J Neurotrauma, 1998; 15: 771–776
  • Choi SC. Sample size in clinical trials with dichotomous endpoints: Use of covariables. J Biopharm Stat 1998; 8: 367–375
  • O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549-556
  • Whitehead J, Stratton I. Group sequential clinical trials with triangular continuation regions. Biometrics 1983; 39: 227–236
  • Ederer P. Practical problems in collaborative clinical trials. Am J Epidemio 11975; 102: 111-118
  • Sylvester RJ, Pinedo HM, Depauw N, et al. Quality of institutional participation in multicenter clinical trials. N Eng1J Med 1981; 305: 852–855
  • Bracken MB. Methodological issues in the design of traumatic brain injury Phase III trials: A call for larger, simpler trials. Neurosurgery 2001 (in press)
  • Doppenberg E, Bullock R. Clinical neuroprotection trials in severe traumatic brain injury: Lessons from previous studies. J Neurotrauma 1997; 14: 71–79

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.